摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

cleomiscosin A | 1137653-03-2

中文名称
——
中文别名
——
英文名称
cleomiscosin A
英文别名
cleomiscosin B;cleomiscosin C;9H-Pyrano(2,3-f)-1,4-benzodioxin-9-one, 2,3-dihydro-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-5-methoxy-, trans-(+-)-;(2S,3S)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-5-methoxy-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one
cleomiscosin A化学式
CAS
1137653-03-2
化学式
C20H18O8
mdl
——
分子量
386.358
InChiKey
XGADTAYOFHOFIW-RDJZCZTQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    632.7±55.0 °C(Predicted)
  • 密度:
    1.403±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    28
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    104
  • 氢给体数:
    2
  • 氢受体数:
    8

反应信息

点击查看最新优质反应信息

文献信息

  • METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE
    申请人:Moazed Kambiz Thomas
    公开号:US20110280909A1
    公开(公告)日:2011-11-17
    Methods and systems are described for a rapid and sustainable change in the pigment melanin content of melanocytes of the iris stroma, thereby to change the color of the eye. Also described are nanoparticle compositions for lightening the pigmented tissues or treating a pigmented tissue related disease.
    描述了一种快速和可持续改变虹膜基质黑色素含量的黑色素细胞的方法和系统,从而改变眼睛的颜色。还描述了用于淡化有色组织或治疗有色组织相关疾病的纳米颗粒组合物。
  • Method and system for effecting changes in pigmented tissue
    申请人:Moazed Kambiz Thomas
    公开号:US20120207809A1
    公开(公告)日:2012-08-16
    Methods and systems are described for a rapid and sustainable change in the pigment melanin content of melanocytes of the iris stroma, thereby to change the color of the eye. Also described are compositions for lightening or darkening the pigmented tissues or treating a pigmented tissue disease.
    本文描述了一种快速和可持续改变虹膜基质黑素细胞中黑色素含量的方法和系统,从而改变眼睛的颜色。还描述了用于使色素组织变浅或变深或治疗色素组织疾病的组合物。
  • Cancer chemopreventative compounds and compositions and methods of treating cancers
    申请人:——
    公开号:US20020193425A1
    公开(公告)日:2002-12-19
    A composition and method of cancer treatment is disclosed. The composition and method utilize brusatol, bruceantin, glaucarubolone, and derivatives thereof as active cancer treating agent in mammals, including humans.
    本研究公开了一种癌症治疗组合物和方法。该组合物和方法利用布鲁沙托、布鲁沙托、格拉鲁勃龙及其衍生物作为哺乳动物(包括人类)的活性癌症治疗剂。
  • Immunomodulatory pharmaceutical composition and a process for preparation thereof
    申请人:Khanuja Preet Singh Suman
    公开号:US20070258989A1
    公开(公告)日:2007-11-08
    The present invention provides a novel pharmaceutical composition consisting of a combination of three coumarinolignoids of formula 1, 2 and 3 isolated from the seeds of the plant Cleome viscose along with a pharmaceutically acceptable carrier useful as a immunomodulator. The invention also describes the ability of the compounds to modulate humorral and cell mediated immune response. It further provides a process for the preparation of a novel pharmaceutical composition of the said three coumarinolignoids in an optimized ratio to modulate humorral and cell mediated immune response.
  • MAPLE TREE-DERIVED PRODUCTS AND USES THEREOF
    申请人:Barbeau Julie
    公开号:US20130310332A1
    公开(公告)日:2013-11-21
    The present document describes a neutraceutical, cosmeceuticals, functional food, pharmaceutical, food ingredient, and non-food ingredient compositions comprising sugar maple extract, essential oil compositions comprising oil extracted from an Acer tree, sweetening compositions containing sugar extracted from maple tree leaves, food ingredients comprising maple tree extract, cosmetic composition comprising maple tree extracts, infusion compositions prepared from maple tree leaves, maple roots, maple wood, maple stems of leaves and samara, and stems/twigs as well as compounds isolated from sugar maple biomass and the methods of extracting the same.
查看更多

同类化合物

黄花菜木脂素B 瑞香替西 (2S,3S)-daphneticin repenin D cleomiscosin A methyl ether ethyl 3,9-dihydro-3-(4-hydroxy-3-methoxyphenyl)-7-methyl-9-oxo-2H-[1,4]dioxino[2,3-h] chromene-2-carboxylate repenin B ethyl 3,9-dihydro-3-(3,4-dihydroxyphenyl)-7-methyl-9-oxo-2H-[1,4]dioxino[2,3-h]chromene-2-carboxylate repenin C moluccanin molucannin diacetate 8'-epi-cleomiscosin A cleomiscosin A (2S,3S)-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-5-methoxy-9H-[1,4]dioxino[2,3-h]chromen-9-one Cleomiscosin D cleomiscosin A monoacetate cleomiscosin D hyosgerin (7′R,8′R)-cleomiscosin C cleomiscosin A diacetate isodaphneticin (3R)-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-methoxy-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one 5'-Demethylaquillochin (2R,3R)-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-2,3-dihydropyrano[3,2-g][1,4]benzodioxin-7-one cis regioisomer of proparcin regioisoner of proparcin propacin compound-B cleomiscosin A daphneticin cleomiscosin A 6-methoxy-5′′-demethoxydaphneticin [4-[2-(Hydroxymethyl)-5-methoxy-9-oxo-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-3-yl]-2-methoxyphenyl] 3-phenylprop-2-enoate 2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-7H-pyrano[2,3-g][1,4]benzodioxin-7-one 2-(Hydroxymethyl)-3-[3-methoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one Cleomiscosin A methyl ether 3-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(8-oxo-[1,3]dioxolo[4,5-h]chromen-2-yl)-2H-pyrano[3,2-h][1,4]benzodioxin-9-one 6-Chloro-3-(4-hydroxy-3-methoxyphenyl)-5-methoxy-2-methyl-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one 2-[3,5-Dimethoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-(hydroxymethyl)-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one Cleomiscosin B [3-(4-Hydroxy-3,5-dimethoxyphenyl)-5-methoxy-9-oxo-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-2-yl]methyl 3,4-dihydroxybenzoate aquillochin methyl ether 2-(3-Hydroxy-4-methoxyphenyl)-3-methyl-2,3-dihydropyrano[2,3-g][1,4]benzodioxin-7-one 2-(3,4-Dihydroxy-5-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydropyrano[2,3-g][1,4]benzodioxin-7-one [3-(3,4-Dimethoxyphenyl)-5-methoxy-9-oxo-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-2-yl]methyl acetate 3-[3,5-Dimethoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2-(hydroxymethyl)-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one [3-(4-Hydroxy-3,5-dimethoxyphenyl)-5-methoxy-9-oxo-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-2-yl]methyl acetate [2-Methoxy-4-(5-methoxy-2-methyl-9-oxo-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-3-yl)phenyl] acetate 3-(4-Hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one [3-(4-Hydroxy-3-methoxyphenyl)-5-methoxy-9-oxo-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-2-yl]methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate